Inflammatory Bowel Diseases

Cover image for Vol. 14 Issue S2

Supplement: A Clinician's Guide to Common Questions in IBD

October 2008

Volume 14, Issue S2

Pages S1–S280

Issue edited by: Dr. Alan Thomson, Dr. Claudio Fiocchi, Dr. Jeffry Katz, Dr. Cosimo Prantera

  1. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Is there a gender difference in the prevalence of Crohn's disease or ulcerative colitis? (pages S2–S3)

      Steven R. Brant and Geoffrey C. Nguyen

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20540

    2. What is the peak age for onset of IBD? (pages S4–S5)

      Richard D. Johnston and Richard F.A. Logan

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20545

    3. Does inflammatory bowel disease develop in infants? (pages S6–S8)

      Michael D. Kappelman and Richard J. Grand

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20544

    4. Inflammatory bowel disease: The difference between children and adults (pages S9–S11)

      Judith Kelsen and Robert N. Baldassano

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20560

    5. Is IBD different in the elderly? (pages S12–S13)

      Simon Travis

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20605

  2. Is Smoking Tobacco a Risk for Developing IBD?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. What is the link between the use of tobacco and IBD? (pages S14–S15)

      Jacques Cosnes

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20555

    2. Is there a threshold for the deleterious effect of smoking in Crohn's disease? (pages S16–S17)

      Raghuram P. Reddy and William J. Tremaine

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20692

  3. Is there a Familial or Genetic Component for the Development of IBD?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Does IBD run in families? (pages S20–S21)

      R.K. Russell and J. Satsangi

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20573

    2. Are there any ethnic groups that are more likely to develop IBD? (pages S24–S25)

      Chris S. Probert and Matt Brown

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20601

    3. I am Jewish: What is my risk of developing Crohn's disease? (pages S26–S27)

      Brian Yan, Remo Panaccione and Lloyd Sutherland

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20691

    4. How do genetics help an understanding of IBD epidemiology? (pages S29–S30)

      Cyrus P. Tamboli

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20690

  4. What are some of the other causes of IBD?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Is IBD associated with a stressful lifestyle? (pages S33–S34)

      P. Dunckley and Simon Travis

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20553

    2. Is diet a factor in the pathogenesis of IBD? (pages S35–S36)

      J.O. Hunter

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20547

    3. Is IBD caused by a Helicobacter pylori infection? (pages S37–S38)

      Carlo A. Fallone and Alain Bitton

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20552

    4. Breastfeeding and inflammatory bowel disease (pages S39–S40)

      A. Farrukh and J.F. Mayberry

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20569

  5. Does IBD Affect Pregnancy?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. IBD and pregnancy (pages S43–S44)

      Philippe Marteau

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20565

  6. What can the IBD Patient Expect Over Time?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. How does IBD affect quality of life? (pages S45–S46)

      Harris R. Clearfield

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20556

    2. How often do patients with IBD have symptom recurrence? (page S47)

      Gabriele Moser

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20564

    3. What is the prognosis of Crohn's disease? (pages S50–S51)

      Tine Jess

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20619

    4. What is the prognosis of ulcerative colitis? (pages S52–S53)

      Kevin Rioux

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20574

    5. Does the behavior of Crohn's disease change over time? (pages S54–S55)

      Edouard Louis, Catherine Reenaers and Jacques Belaiche

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20561

    6. Is narcotic addiction more prevalent in IBD patients? (page S56)

      Hugh J. Freeman

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20549

    7. What is the cancer risk in Crohn's disease? (pages S63–S64)

      Hugh J. Freeman

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20550

  7. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Are clinical outcomes in IBD improved by multidisciplinary clinics? (page S65)

      Joy Mekechuk and Levinus A. Dieleman

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20554

    2. What is the role of patient education in the care of IBD? (pages S66–S67)

      R.C. Rakshit and J.F. Mayberry

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20622

    3. How often do IBD patients require resection of their intestine? (pages S68–S69)

      L. Hancock and N.J. Mortensen

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20600

    4. Are patients with IBD knowledgeable about the risks of their medications? (pages S70–S71)

      John Keohane and Fergus Shanahan

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20620

    5. Are there different types of Crohn's disease? (pages S75–S76)

      David B. Sachar

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20572

  8. Pathophysiology

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Why are genetic studies important in IBD? (pages S79–S80)

      A.S. Peña

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20676

    2. Is genomic analysis relevant to IBD? (pages S81–S82)

      Shukti Chakravarti

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20684

    3. What is the role of the enteric commensal flora in IBD? (pages S83–S84)

      Francisco Guarner

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20548

    4. Is there a role for defensins in IBD? (pages S85–S87)

      Jan Wehkamp and Eduard F. Stange

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20698

    5. What are toll-like receptors and what role may they have in IBD? (pages S90–S92)

      Masayuki Fukata and Maria T. Abreu

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20632

    6. Do antibodies have a role in IBD pathogenesis? (pages S95–S96)

      M. Vecchi, L. Spina, F. Cavallaro and L. Pastorelli

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20699

    7. Is IBD an autoimmune disorder? (pages S97–S101)

      Kiron M. Das and Livia Biancone

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20723

    8. Do heat shock proteins play any role in gut inflammation? (pages S102–S103)

      Mae J. Ciancio and Eugene B. Chang

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20697

    9. Why are molecular mechanisms of immune activation important in IBD? (pages S106–S107)

      Giovanni Monteleone and Flavio Caprioli

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20678

    10. Nf-κB signaling cascade and IBD: Turn it down? (pages S108–S109)

      Christian Jobin

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20717

    11. Can loss of immune tolerance cause IBD? (pages S115–S116)

      Jochen Maul and Rainer Duchmann

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20679

    12. What is the role of cytokines and chemokines in IBD? (pages S117–S118)

      Daniele Fina and Francesco Pallone

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20677

    13. What is the role of growth factors in IBD? (pages S119–S120)

      Raymond John Playford and Subrata Ghosh

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20669

    14. Why are cytokines targeted for biological therapy in IBD? (pages S121–S122)

      Masayuki Saruta and Konstantinos A. Papadakis

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20631

    15. Do non-immune cells have a role in IBD? (pages S123–S124)

      Y.R. Mahida and G.W. Moran

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20680

    16. Does the mucosal microcirculation play a role in IBD? (pages S125–S126)

      Silvio Danese and Livija Deban

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20716

    17. What are the mechanisms of fibrosis in IBD? (pages S127–S128)

      P. Kay Lund and Rachael J. Rigby

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20681

    18. Why study animal models of IBD? (pages S129–S131)

      Warren Strober

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20667

    19. Do different animal models of IBD serve different purposes? (pages S132–S133)

      Matthew B. Grisham

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20682

    20. What is the effect of inflammation on intestinal function? (pages S140–S144)

      Giovanni Barbara, Vincenzo Stanghellini, Cesare Cremon, Roberto De Giorgio and Roberto Corinaldesi

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20701

  9. Clinical Diagnosis of IBD

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. How can IBD be distinguished from IBS? (pages S152–S154)

      Philip M. Ginsburg and Theodore M. Bayless

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20696

    2. How useful is the Vienna Classification in clinical practice? (page S161)

      Fernando Tavarela Veloso

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20616

  10. Pathologic Diagnosis of IBD

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Does rectal sparing ever occur in ulcerative colitis? (pages S166–S167)

      Jonathan N. Glickman and Robert D. Odze

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20592

  11. Imaging in IBD

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. What is the role of endoscopy in the postoperative management of Crohn's disease? (pages S179–S180)

      Paul Rutgeerts and Gert Van Assche

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20655

    2. Radiologic testing in Crohn's disease (pages S181–S182)

      Leonard Baidoo and Miguel Regueiro

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20614

    3. What is the role of endoscopy in predicting crohn's disease relapse or course? (pages S183–S184)

      Paul Rutgeerts, Severine Vermeire and Gert Van Assche

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20721

  12. Biomarkers and Diagnosis of IBD

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. What is the role and significance of serum and stool biomarkers in the diagnosis of IBD? (pages S187–S189)

      Ron Palmon, Steven J. Brown and Maria T. Abreu

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20714

    2. Should family members of IBD patients be screened for CARD15/NOD2 mutations? (pages S190–S191)

      Severine Vermeire, Gert Van Assche and Paul Rutgeerts

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20587

  13. Cancer and IBD

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
  14. Extraintestinal Manifestations and IBD

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
  15. How do Physicians make their choice of therapy to recommend to Patients with IBD?

    1. Top of page
    2. What are the Epidemiological Differences between Crohn's Disease and Ulcerative Colitis?
    3. Is Smoking Tobacco a Risk for Developing IBD?
    4. Is there a Familial or Genetic Component for the Development of IBD?
    5. What are some of the other causes of IBD?
    6. Does IBD Affect Pregnancy?
    7. What can the IBD Patient Expect Over Time?
    8. Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?
    9. Pathophysiology
    10. Clinical Diagnosis of IBD
    11. Pathologic Diagnosis of IBD
    12. Imaging in IBD
    13. Biomarkers and Diagnosis of IBD
    14. Cancer and IBD
    15. Extraintestinal Manifestations and IBD
    16. How do Physicians make their choice of therapy to recommend to Patients with IBD?
    1. Could stress play a role in IBD? (pages S206–S207)

      Susan Levenstein

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20663

    2. Adverse events of IBD therapies (pages S210–S211)

      Maria Lia Scribano

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20702

    3. How do you avoid and treat steroid side effects? (pages S214–S215)

      Simon Travis

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20649

    4. Use of combination therapy in IBD (pages S219–S221)

      Gil Kaplan and Remo Panaccione

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20688

    5. What is the optimal therapy for severe ulcerative colitis? (pages S228–S231)

      Richard P. MacDermott, Jesse A. Green and Christopher C. Ashley

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20514

    6. How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis? (pages S238–S239)

      Sandro Ardizzone and Gabriele Bianchi Porro

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20671

    7. When is it time for surgery in severe ulcerative colitis? (page S240)

      Cosimo Prantera

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20694

    8. Which therapies are advisable in pouchitis? (pages S241–S242)

      P. Gionchetti, F. Rizzello, R. Tambasco, G. Straforini, G. Poggioli, C. Calabrese, R. Brugnera and M. Campieri

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20709

    9. Is it always necessary to treat CD patients? (pages S245–S246)

      Emma Calabrese and Francesco Pallone

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20656

    10. Medical induction of active Crohn's ileitis: Evidence-based management (pages S247–S248)

      Kerri Novak, Lloyd Sutherland and Remo Panaccione

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20711

    11. Are antibiotics useful in the treatment of IBD? (pages S249–S250)

      Saleh Alqhatani, Lloyd Sutherland and Remo Panaccione

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20707

    12. How do you judge relapse in Crohn's disease? (pages S253–S254)

      Morten H. Vatn

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20706

    13. What are the guidelines for using biologics in pediatric patients? (pages S259–S261)

      Edwin de Zoeten and Petar Mamula

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20653

    14. What are the rules when treatment with 6-MP/AZA is started? (pages S262–S263)

      Burton I. Korelitz

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20705

    15. Management of perianal fistula in Crohn's disease (pages S266–S268)

      Ben Siemanowski and Miguel Regueiro

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20708

    16. What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease? (pages S275–S276)

      Gert Van Assche, Séverine Vermeire and Paul Rutgeerts

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20648

    17. Adhesion molecule therapeutics in IBD (pages S279–S280)

      Bruce R. Yacyshyn

      Version of Record online: 24 SEP 2008 | DOI: 10.1002/ibd.20710

SEARCH

SEARCH BY CITATION